EdgeTestMarket TodayOptions TodayIPO
Start free

FISCHERFischer Medical Ventures Limited

Rs 27▲ +8.52%
Market closedEquity EOD 26 Oct
Compare
52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.5.2% up the range
Rs 22Rs 122
FISCHER price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 26 Oct
IndicatorsVolume

Loading FISCHER price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 1,767 cr
Larger than 83% of 6 peers
sector middle Rs 744 cr
P/EPrice to earnings: how many rupees investors pay for each rupee of profit the company made over the last twelve months. Compare it with similar companies rather than reading it alone.
10.6x
Lower than 80% of 5 peers
sector middle 46.5x
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
4.6x
Higher than 80% of 5 peers
sector middle 2.5x
ROEReturn on equity: the year's profit as a percentage of the shareholders' money in the business. It shows how much the company earns on what its owners have put in.
7.7%
Lower than 60% of 5 peers
sector middle 9.9%
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
12.7%
Higher than 80% of 5 peers
sector middle 11.5%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.19
Higher than 80% of 5 peers
sector middle 0.10
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.0%
Higher than 80% of 5 peers
sector middle 0.0%
Sales growthHow much the latest quarter's sales grew against the same quarter a year earlier.
+249.4%
Highest of 5 peers
sector middle +18.0%

Peers are the listed companies in the exchange's own industry group: Medical Equipment & Supplies. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 14 Aug 2026), sales rose 249.4% from a year earlier to Rs 81.9 cr and profit fell 24.3% to Rs 3.8 cr.

Worth watching
  • Operations used cash in FY26 (-Rs 101 cr) while reported profit was Rs 31.0 cr.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 5 results, the share rose on 3 and fell on 2, and moved by 3% or more on 4.

Q1 FY26Q3 FY26Q1 FY27

Q1 FY27: results filed 14 Aug 2026. The share went from its close on 13 Aug 2026 to its close on 17 Aug 2026 -3.92%.

Fundamentals
Trailing-twelve-month valuation, margins and growth from the company's own filings.
as of 2026-06-30
P/E (TTM)
10.6
PEG
-
EPS (TTM)
Rs 2.5
Net margin
8.1%
Rev growth YoY
+249.42%
Profit growth YoY
-24.30%
TTM revenue
Rs 367 Cr
TTM net profit
Rs 30 Cr
What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 671 Cr of assets. Its owners funded 57% of that and borrowings 11%.

What it owns
18%
43%
31%
Plant, property and projects15 Cr
Goodwill and intangibles5 Cr
Investments118 Cr
Inventory13 Cr
Owed by customers289 Cr
Cash and bank25 Cr
Everything else206 Cr
How that is paid for
57%
11%
15%
17%
Shareholders385 Cr
Borrowings72 Cr
Owed to suppliers103 Cr
Other liabilities111 Cr
Cash and equivalents
Rs 12 Cr
Net debt
Rs 60 Cr
Current ratio
1.62x
short-term assets per rupee due soon
Book value / share
Rs 6
Return on assets
4.4%
EV / EBITDA
33.0x

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs -101 Cr, spent Rs 1 Cr on plant and equipment, and cash fell by Rs 92 Cr over the year.

From running the business
-101 Cr
Spent on or received from investing
-5 Cr
From or to lenders and shareholders
+14 Cr
Net change in cash
-92 Cr

Full financial year to 2026-03-31, from the company's cash flow statement.

Against its sector
Where this stock sits within its own sector on each measure. The marker is its position in the peer group and the notch is the sector median. A position is a fact about the cohort, not a view on the stock.
Medical Equipment & Supplies · 16
P/E10.59vs 46.47 median
Cheapest: FABTECH 8.84Priciest: TARSONS 142.73
Net margin8.12%vs 10.77% median
Lowest: TARSONS 2.51%Highest: POLYMED 15.67%
Revenue growth249.42%vs 18.04% median
Lowest: FABTECH 10.26%Highest: FISCHER 249.42%
Compared against
APRAMEYAAVIENCEDENTALKARTFABTECHGKBGMLLAXMIDENTLMADHAVBAUGMHHLMOLBIONURECAOSELDEVICEPOLYMEDQLINEQMSMEDITARSONS

Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.

Peers side by side
Every company in the same NSE industry group that we hold figures for, largest first. Tap any heading to sort by it. The same figures as the At a glance tiles, worked out the same way for every company.
Medical Equipment & Supplies · 7 shown
Company
POLYMED
Poly Medicure Limited
14,631 cr46.5x4.7x9.9%13.2%0.1115.7%+30.3%0.24%
FISCHER
Fischer Medical Ventures Limited
1,767 cr10.6x4.6x7.7%12.7%0.198.1%+249.4%0.02%
TARSONS
Tarsons Products Limited
1,587 cr142.7x2.5x1.8%4.8%0.602.5%+20.7%0.00%
LAXMIDENTL
Laxmi Dental Limited
945 cr30.5x3.9x12.7%11.5%0.0010.8%+13.9%0.00%
FABTECH
Fabtech Technologies Limited
543 cr8.8x1.3x11.6%11.6%0.1011.7%+10.3%0.00%
QMSMEDI
QMS Medical Allied Services Limited
334 cr--------
NURECA
Nureca Limited
296 cr72.1x1.6x2.4%3.4%0.002.8%+18.0%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
5 quarters
RevenueRs 82 Cr
Net profitRs 4 Cr
Jun 255 quarters filedJun 26

Each bar is one quarter as filed with the exchange, newest on the right, so the seasonal shape of the business is visible rather than smoothed away. Hover any quarter for its full figures and the change against the same quarter a year earlier. Revenue and profit are drawn on separate scales because they differ by an order of magnitude; reading one against the other would be misleading.

Dividends paid
Cash paid per share, from the exchange's corporate-action record, restated to today's share count across bonuses and splits. Dates shown are ex-dates: you must own the shares before that date to receive the payment.
Rs 19 in 2025
Paid 1 of 1 yrs
what 2025's payouts come to on Rs 1 lakh at today's price · nothing declared in the last twelve months
What each year paid, on Rs 1 lakh
19
25

2025 paid Rs 0.01 per share, about Rs 19 on Rs 1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 3
DatePartySideQtyPriceValue
2026-09-22TRADE SOLVENT PRIVATE LIMITEDBUY64,36,90732.95Rs 21.21 Cr
2026-09-22L7 HITECH PRIVATE LIMITEDSELL64,36,90732.95Rs 21.21 Cr
2026-09-22L7 HITECH PRIVATE LIMITEDBUY3,05,00032.98Rs 1.01 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 26 Oct
RSI (14) - momentum
35.1Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
18.9%Below average - weaker conviction
today 18.9%20d avg 54.8%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-19.90%
vs 200-DMA
-26.70%
1-month
-22.92%
3-month
-28.84%
1-year
-71.67%
Realized vol (30d)
57.4%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on FISCHER?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.